• Publications
  • Influence
Prevention and treatment of cancer-related infections.
Patients with cancer are at increased risk for developing infectious complications during the course of their disease and treatment. The following sections of the NCCN Clinical Practice Guidelines inExpand
  • 288
  • 10
  • PDF
Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.
Infectious diseases are important causes of morbidity and mortality in patients with cancer. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prevention and Treatment ofExpand
  • 81
  • 9
Identification of an Emerging Pathogen, Mycobacterium massiliense, by rpoB Sequencing of Clinical Isolates Collected in the United States
ABSTRACT Mycobacterium massiliense is a rapidly growing mycobacterium that is indistinguishable from Mycobacterium chelonae/M. abscessus by partial 16S rRNA gene sequencing. We sequenced rpoB, sodA,Expand
  • 79
  • 6
Prevention and treatment of cancer-related infections.
Patients with cancer are at increased risk for developing infectious complications during the course of their disease and treatment. The following sections of the NCCN Clinical Practice Guidelines inExpand
  • 65
  • 3
  • PDF
Disseminated Mycobacterium bovis after intravesicular bacillus calmette-Gu rin treatments for bladder cancer.
Transitional-cell carcinoma of the bladder is an aggressive and potentially fatal malignancy. In 1990, the US Food and Drug Administration approved the use of intravesicular bacillus CalmetteGuérinExpand
  • 75
  • 3
  • PDF
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
Tacrolimus is an immunosuppressive drug mainly used to lower the risk of transplant rejection in individuals who are post solid organ or hematopoietic transplantation. It is a macrolide which reducesExpand
  • 23
  • 3
Catheter-related complications of cancer therapy.
  • J. Greene
  • Medicine
  • Infectious disease clinics of North America
  • 1 June 1996
Although the management of CVC-related infection appears complex and at times the literature seems to be contradictory, simple guidelines can direct the clinician in a stepwise fashion. Knowledge ofExpand
  • 60
  • 2
Fever and neutropenia clinical practice guidelines.
Significant progress has been made in managing fever and neutropenia in patients with cancer. Although initial empiric antimicrobial treatment remains the foundation of therapy for such patients,Expand
  • 26
  • 2
Memory rehabilitation
  • J. Greene
  • Journal of Neurology, Neurosurgery & Psychiatry
  • 26 August 2010
  • 27
  • 2
Pathologic manifestations of invasive pulmonary aspergillosis in cancer patients: the many faces of aspergillus.
Invasive pulmonary aspergillosis (IPA) is a fulminant and highly lethal infection of severely immunocompromised patients with a reported mortality rate of approximately 60%.1 Patients who are atExpand
  • 8
  • 2
  • PDF